Fulgent Genetics (FLGT) EBITDA Margin Growth (3y) (2018 - 2026)
Powered by 
Analysis
Fulgent Genetics (FLGT) EBITDA Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 3,294.00 |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 20.00 |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 333.00 |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 4,867.00 |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 1,424.00 |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 941.00 |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 2,869.00 |
| 10 | Fulgent Genetics | 596.80 Mn | 334.14 Mn | 25.68 Mn | -1,307.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,307.00 |
| Mar 31, 2026 | -1,115.00 |
| Dec 31, 2025 | -8,128.00 |
| Sep 30, 2025 | -1,859.00 |
| Jun 30, 2025 | -3,431.00 |
| Mar 31, 2025 | -9,000.00 |
| Dec 31, 2024 | -8,111.00 |
| Sep 30, 2024 | -9,370.00 |
| Jun 30, 2024 | -9,100.00 |
| Mar 31, 2024 | -10,807.00 |
| Dec 31, 2023 | -29,093.00 |
| Sep 30, 2023 | -6,220.00 |
| Jun 30, 2023 | -4,447.00 |
| Mar 31, 2023 | -1,283.00 |
| Dec 31, 2022 | -3,885.00 |
| Sep 30, 2022 | -1,425.00 |
| Jun 30, 2022 | 671.00 |
| Mar 31, 2022 | 9,700.00 |
| Dec 31, 2021 | 7,808.00 |
| Sep 30, 2021 | 8,494.00 |